Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outlook Therapeutics (OTLK) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Outlook Therapeutics (OTLK) over the last 8 years, with Q4 2025 value amounting to $60.2 million.

  • Outlook Therapeutics' Shares Outstanding (Weighted Average) rose 14843.25% to $60.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $60.2 million, marking a year-over-year increase of 14843.25%. This contributed to the annual value of $34.8 million for FY2025, which is N/A changed from last year.
  • As of Q4 2025, Outlook Therapeutics' Shares Outstanding (Weighted Average) stood at $60.2 million, which was up 14843.25% from $34.8 million recorded in Q3 2025.
  • Outlook Therapeutics' Shares Outstanding (Weighted Average)'s 5-year high stood at $60.2 million during Q4 2025, with a 5-year trough of $24.2 million in Q4 2024.